middle.news
ResMed Reports 10% Revenue Growth, Expands Sleep Health with Noctrix Acquisition
8:32am on Friday 14th of August, 2026 AEST
•
Healthcare
Read Story
ResMed Reports 10% Revenue Growth, Expands Sleep Health with Noctrix Acquisition
8:32am on Friday 14th of August, 2026 AEST
Key Points
10% revenue growth to $5.65 billion
Acquisition of Noctrix Health expands sleep health portfolio
MatrixCare business sale for $490 million underway
Net income rises to $1.52 billion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resmed (ASX:RMD)
OPEN ARTICLE